Meet Innerwell, a revolutionary psychedelic therapy platform with an emphasis on therapy. We believe that when deeply personal therapeutic relationships meet the giant leaps we’ve made in psychedelic medicine, unthinkable transformations are possible.
What separates our patient experience?
👩⚕️ Licensed clinicians with specialized training in psychedelic-assisted therapy, starting with Ketamine
📱 Personalized digital care to support patients before, during, and after their experience
📊 Measurement and data focused approach to improving patient outcomes
We’re bringing a true ketamine-assisted psychotherapy experience virtual - and that’s just the beginning, as we’re already working towards expanding the gold standard model of psychedelic therapy for at-home and in-person treatment aided by groundbreaking medicine like psilocybin and MDMA.
What separates our patient experience?
👩⚕️ Licensed clinicians with specialized training in psychedelic-assisted therapy, starting with Ketamine
📱 Personalized digital care to support patients before, during, and after their experience
📊 Measurement and data focused approach to improving patient outcomes
We’re bringing a true ketamine-assisted psychotherapy experience virtual - and that’s just the beginning, as we’re already working towards expanding the gold standard model of psychedelic therapy for at-home and in-person treatment aided by groundbreaking medicine like psilocybin and MDMA.
Employees: 11-50
Total raised: $3M
Founded date: 2021
Investors 3
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Looking Gl... | lookinggla... |
| 03.06.2022 | Greycroft | greycroft.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.06.2022 | Pre-Seed | $3M | Greycroft |
Mentions in press and media 2
| Date | Title | Description |
| 02.06.2022 | 3 reasons companies are still doing SPAC mergers | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Let’s take a brief stroll back to Aug. 2021, shall we? Paid Content How Northrop Grumman uses ESG... |
| 06.03.2022 | Innerwell Raises $3M to Make Psychedelic-Assisted Psychotherapy Mainstream | There has been a resurgence in the debate about the clinical use of Psychedelic therapies or psychedelic-assisted psychotherapy (PAP). There’s been increased legalization of substances and ketamine has been the most-studied psychedelic drug... |